Embecta revenue was $1.12B for the trailing 12 months ending Jun 30, 2024, with 36.4% growth year over year. Quarterly revenue for the quarter (Q2 2024) ending on Jun 30, 2024 was $272.5M, down 5.1% from last quarter. For the last reported fiscal year 2023 ending Sep 30, 2023, EMBC annual revenue was $1.1B, with -0.8% growth year-over-year.
EMBC past revenue growth
How has EMBC's revenue growth performed historically?
On Invalid Date, Embecta (NASDAQ: EMBC) reported Q2 2024 revenue of $272.50 million up 4.75% year over year. In the same quarter last year, Embecta's revenue was $286.10 million.
What was Embecta's revenue in 2023?
Embecta's annual revenue for the twelve months ending Sep 30, 2023 was $1.12 billion, a 0.77% decrease year over year.
How much does Embecta make in a day?
Based on Embecta annual revenue for the past four years, EMBC makes an average of $3,082,945.21 per day.
What was Embecta's annual revenue growth in the past year?
As of Q4 2024, Embecta's revenue has grown 0.48% year over year. This is 8.18 percentage points lower than the US Medical Instruments & Supplies industry revenue growth rate of 8.66%. Embecta's revenue in the past year totaled $1.12 billion.
How much does Embecta make in a year?
Embecta's revenue by year for the past four years is:
Embecta's revenue for the twelve months ending Sep 30, 2023 was $1.12 billion, a 0.77% decrease year over year.
Embecta's annual revenue for Sep 30, 2022 was $1.13 billion, a 3.07% decrease from 2021.
Embecta's annual revenue for 2021 was $1.17 billion, a 7.35% increase from 2020.
Embecta's annual revenue for 2020 was $1.09 billion, a 2.12% decrease from 2019.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.